Veralto (VLTO)
NYSEIndustrialsPollution & Treatment ControlsSnapshot 2026-07-07
$93.11+0.68%
Close 2026-07-07 · 1-day change
Reading VLTO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track VLTO free→NYSEIndustrialsPollution & Treatment ControlsSnapshot 2026-07-07
Reading VLTO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track VLTO free→QuarterlyIQ Insights · VLTO
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $93.11. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $93 VLTO trades at 23× p/e, below its 35× p/e peer median. Our $98 fair value sits above the price. It's a high-confidence read. Analysts target $103–$113. Note: our $98 fair value sits below the entire analyst range ($103–$113). Not investment advice.
$103.00 – $113.00 (median $110.00) · 3 analysts · as of 2026-04-30
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $3.80/sh owner earnings.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $110.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $104.99 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $108.03 | — | — | Hist. CAGR | high |
| graham number | 12M | $33.07 | — | — | TTM | high |
| Mgmt guidance | 12M | $149.90 | 35.4 | 4.24 | Mgmt | high |
| Peer EV/EBITDA | 12M | $87.05 | 16.6 | 5.54 | TTM | high |
| Peer P/FCF | 12M | $102.00 | 24.4 | 4.18 | TTM | high |
| Peer P/E | 12M | $149.90 | 35.4 | 4.24 | TTM | high |
| Peer P/S | 12M | $75.23 | 3.4 | 22.44 | TTM | high |
| PEG | 12M | $116.50 | 27.5 | 4.24 | TTM | high |
| residual income | 12M | $25.30 | — | — | TTM | high |
| Own P/E history | 12M | $96.57 | 22.8 | 4.24 | TTM | high |
| triangulated | 12M | $145.75 | 35.4 | 4.12 | Triangulated | high |
| Mgmt guidance | 3Y | $200.82 | 35.4 | 5.68 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $113.43 | 24.4 | 4.65 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $183.08 | 35.4 | 5.18 | Analyst | medium |
| Peer P/S | 3Y | $92.41 | 3.4 | 27.57 | Analyst | medium |
| PEG | 3Y | $142.28 | 27.5 | 5.18 | Analyst | medium |
| Own P/E history | 3Y | $117.95 | 22.8 | 5.18 | Analyst | medium |
| Mgmt guidance | 5Y | $244.06 | 35.4 | 6.90 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $121.76 | 24.4 | 4.99 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $209.38 | 35.4 | 5.92 | Analyst | high |
| Peer P/S | 5Y | $105.69 | 3.4 | 31.53 | Analyst | high |
| PEG | 5Y | $162.72 | 27.5 | 5.92 | Analyst | high |
| Own P/E history | 5Y | $134.89 | 22.8 | 5.92 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.